KLTO - ANEW Medical Market Valuation

Public company logo of ANEW Medical, Inc. (KLTO)

This chart of Klotho Neurosciences Inc (KLTO) stock quotes showcases a company developing Klotho protein-based biologics to combat ALS and dementia. The current metric stands at 0.04. The business relies on stable demand for biotechnology, establishing it as a defensive asset regardless of macroeconomic conditions. Klotho Neurosciences Inc also focuses on Parkinson's disease therapy, aiming to restore cognitive functions in the elderly.

KLTO ANEW Medical: Market Value in the range 09/18/2024 - 03/11/2026

KLTO (anewmeds.com): analytical breakdowns and indicator data

- market price and analyst price targets:
Price Chart Klotho Neurosciences|KLTO - Price Target Chart
- market capitalization statistics:
Market Valuation KLTO|KLTO - Aggregate Business Value
- business book valuation details:
Net Assets per Single Share Klotho Neurosciences|KLTO - Total Stockholders' Equity|Market Value to Book Value Ratio anewmeds.com|KLTO - Total Business Assets
- debt obligations and liquidity statistics:
Total Debt to Capital Klotho Neurosciences Inc|KLTO - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio Klotho Neurosciences|KLTO - Company Aggregate Debts|Debt to Book Capitalization Ratio KLTO|KLTO - Company Long-Term Loans and Borrowings|Company Short-Term Debt Klotho Neurosciences|Quick Liquidity anewmeds.com
- business earnings and investment ratios data:
KLTO - Net Profit|Expected Profit Klotho Neurosciences Inc|KLTO - Price to Earnings Ratio|Future Price to Earnings Klotho Neurosciences|KLTO - Price to Earnings Adjusted for Growth Rate|Enterprise Value to EBITDA Ratio KLTO|KLTO - Company profit before taxes, interest and amortization|Net earnings per share (EPS TTM) Klotho Neurosciences|KLTO - Earnings per share for the trailing year|Year-over-year earnings per share growth for the last twelve months anewmeds.com|KLTO - Earnings per share growth rate in current year|Expected earnings per share growth for next year Klotho Neurosciences Inc
Fundamental company analysis:KLTO (ANEW Medical, Inc.)
Product sample of ANEW Medical

Klotho Neurosciences Inc (KLTO) operates in the high-risk neurobiological research sector without current operating revenue. Business value here depends not on profit, but on the market valuation of the potential for future therapeutic discoveries. Market capitalization represents the product of the share price and the total number of issued securities. This indicator reflects the aggregate investor demand for the company's scientific achievements. By analyzing the market capitalization dynamics of Klotho Neurosciences Inc (KLTO), one can identify periods of speculative overheating or asset undervaluation.

Key competitors

Market Value Biogen BIIB|Neurocrine - Market Value|RGC: Market Valuation|Axsome Corp - Market Value|ACADIA Pharmaceuticals (ACAD) - Market Value|Market Value xenon-pharma.com (XENE)|Market Value Viking Therapeutics, Inc.|Market Capitalization SUPN (Supernus Pharmaceuticals, Inc.)|Market Capitalization CPRX|DNLI - Market Value|Harmony Biosciences - Market Valuation|Market Capitalization biohavenpharma.com BHVN|AMLX - Market Value|Market Value TRVI (Trevi Therapeutics Inc)|Praxis Medicines (PRAX) - Market Value|Market Value Anavex Life Sciences Corp (AVXL)|Market Value CeriBell, Inc.|Market Capitalization Prothena Corp|Market Value Alector, Inc. (ALEC)|Market Value ANNX (Annexon Biosciences)|Market Value Omeros OMER|Neurogene Therapeutics (NGNE) - Market Value|ACIU: Market Valuation|voyagertherapeutics.com - Market Value|NMRA: Market Capitalization|Scilex Holding - Market Value|Market Value Tevogen Bio Holdings, Inc.|Market Value Alpha Cognition Corp ACOG|Market Valuation CGTX (Cognition Therapeutics, Inc.)|IKT (inhibikase.com) - Market Value|Market Value Cassava Sciences SAVA|ASRT: Market Capitalization|Coya - Market Capitalization|Market Value Vistagen Therapeutics|OVID (ovidrx.com) - Market Valuation|acumenpharm.com (ABOS) - Market Capitalization|Market Value CervoMed|ATHE: Market Value|Market Value Clene Inc. (CLNN)|PEPG - Market Value|Market Value Jupiter Neurosciences JUNS|Market Capitalization relmada.com (RLMD)|Annovis Bio - Market Capitalization|Grace Therapeutics, Inc. (GRCE) - Market Valuation|AIFF: Market Capitalization|NRSN - Market Capitalization|RVPH (Reviva Pharmaceuticals) - Market Capitalization|Market Value MetaVia, Inc. MTVA|Market Value NeurAxis (NRXS)|heliusmedical.com - Market Capitalization|Market Capitalization PASG (Passage Bio)|NEUP - Market Valuation|Minerva Neurosciences - Market Capitalization|Market Value athira.com|Addex Therapeutics Ltd (ADXN) - Market Value|ALZN - Market Capitalization|Market Valuation CYCN|PTIX: Market Value|Market Capitalization KTTA|Market Capitalization cortigent.com|Market Value Avenue Therapeutics, Inc. ATXI|BCLI: Market Capitalization|Cara Therapeutics, Inc - Market Capitalization|Chromocell (CHRO) - Market Valuation|eliemtx.com (ELYM) - Market Value|Intra-Cellular Therapies, Inc. (ITCI) - Market Capitalization|Market Value Longboard Pharmaceuticals, Inc.|Market Value MRNS|Market Valuation NKGN (NKGen)|Market Value NRBO|Market Value Sage Therapeutics, Inc. SAGE|synaptogen.com (SNPX) - Market Value|TRVN - Market Value|VIGL (Vigil Neuroscience) - Market Capitalization|WENA: Market Capitalization|Market Value Cerevel Corp (CERE)